Skip to main content
SpringerLink
Log in

Prejunctional Effects of Neuropeptide Y and Its Role as a Cotransmitter

  • Chapter
Neuropeptide Y and Related Peptides

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 162))

Abstract

Neuropeptide Y (NPY) has been shown to be colocalized and coreleased with noradrenaline (NA) and adenosines-5′-triphosphate (ATP) in most sympathetic nerves in the peripheral nervous system, especially those innervating blood vessels. There is also convincing evidence that NPY exerts prejunctional modulatory effects on transmitter release and synthesis. Moreover, there are numerous examples of postjunctional interactions that are consistent with a cotransmitter role for NPY at various sympathetic neuroeffector junctions. This chapter will provide convincing evidence that NPY does function physiologically as the third sympathetic cotransmitter together with NA and ATP. The functions of NPY include: (a) direct postjunctional contractile effects; (b) potentiation of the contractile effects of the other sympathetic cotransmitters, NA and ATP; and (c) inhibitory modulation of the nerve stimulation-induced release of all three sympathetic cotransmitters. Studies with selective NPY- Y1 antagonists provide evidence that the principal postjunctional receptor is of the Y1 subtype although information is incomplete and other receptors are also present at some sites and may exert physiological actions. Studies with selective NPY- Y2 antagonist suggest that the principle prejunctional receptor is of the Y2 subtype both in the periphery and central nervous system (CNS). Again, there is evidence for a role for other NPY receptors and clarification awaits the further development of selective antagonists. NPY can also act prejunctionally to inhibit the release of acetylcholine, calcitonin gene related peptide (CGRP) and substance P. In the CNS, NPY exists as a cotransmitter with catecholamines in some neurons and with peptides and mediators in other neurons. A prominent action of NPY is the presynaptic inhibition of the release of various neurotransmitters including NA, dopamine (DA), gamma-aminobutyric acid, glutamate, serotonin as well as inhibition or stimulation of various neurohormones such as luteinizing hormone (LH), luteinizing hormone releasing hormone, vasopressin, oxytocin as well as others. Evidence also exists for stimulation of NA and DA release. NPY also acts on autoreceptors to inhibit the release of itself. There is evidence that NPY may use several mechanisms to produce its prejunctional/presynaptic effects including: inhibition of calcium channels, activation of potassium channels and perhaps regulation of the vesicle release complex at some point post calcium entry. NPY may also play a role in several pathophysiological conditions. The therapeutic manipulation of NPY release and the development of further selective agonists and antagonist should to be an important goal of future research in order to further understand the physiological and pathophysiological role of NPY.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adewale S, Macarthur H, Westfall TC (2001) Modulation of catecholamine synthesis by neuropeptide Y in rat Striatal slices. Exp Biol 15:H453.7

    Google Scholar 

  • Adrian TE, Allen JM, Bloom SR, Ghatei MA, Rossor M.N, Roberts GW, Crow TJ, Tatemoto K, Polak JM (1983) Neuropeptide Y distribution in human brain. Nature 306:584–586

    PubMed  CAS  Google Scholar 

  • Allen JM, Adrian TE, Polak JM, Bloom SR (1983a) Neuropeptide Y in the adrenal gland. J Auton Nerv Syst 9:599–563

    Google Scholar 

  • Allen JM, Bloom SR (1986) Neuropeptide Y: a putative neurotransmitter. Neurochem Int 8:1–8

    PubMed  CAS  Google Scholar 

  • Allen JM, Adrian TE, Tatemoto K, Polak JM, Hughes J, Bloom SR (1982) Two novel related peptides, neuropeptide Y and peptide YY inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides 3:71–77

    PubMed  CAS  Google Scholar 

  • Allen JM, Bircham PMM, Edwards AV, Tatemoto K, Bloom SR (1983b) Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regul Peptides. 6:247–253

    CAS  Google Scholar 

  • Allen JM, Birchan MM, Bloom SR, Edwards AV (1984) Release of neuropeptide Y in response to splann nerve stimulation in the conscious calfs. J Physiol (Lond) 357:405–408

    Google Scholar 

  • Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM (1983c) Neuropeptide Y distribution in the rat brain. Science 221–879

    Google Scholar 

  • Archelos J, Xlang JZ, Reinecke M, Lang RC (1987) Regulation of release and function of neuropeptides in the heart. J Cardiovas Pharm 10(Suppl 12):45–50

    Google Scholar 

  • Ault DT, Werling LL (1997) Differential modulation of NMDA stimulated 3H-dopamine release from rat striatum by neuropeptide Y and σ receptor ligands. Brain Res 760:210–217

    PubMed  CAS  Google Scholar 

  • Ault DT, Radeff JM, Werling LL (1998) Modulation of 3H-dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma 1-like receptor. J Pharmacol Exp Ther 284:553–560

    PubMed  CAS  Google Scholar 

  • Beal F, Frank RC, Ellison DW, Martin JB (1986) The effect of neuropeptide Y on Striatal catecholamines. Neurosci Lett 71:118–123

    PubMed  CAS  Google Scholar 

  • Bendotti C, Hohmann C, Furlough G, Reeves R, Coyl JT, Oster-Granite NL (1990) Developmental expression of somatostatin in mouse brain: In situ hybridization. Brain Res Develop 53:26–39

    CAS  Google Scholar 

  • Bitran M, Tapia W, Eugenin E, Orio P, Boric MP (1999) Neuropeptide Y induced inhibition of noradrenaline release in rat hypothalamus: role of receptor subtype and nitric oxide. Brain Res 851:87–93

    PubMed  CAS  Google Scholar 

  • Bleakman D, Comers WF, Fournier A, Miller RJ (1991) Neuropeptide Y inhibits Ca2+ influx into cultured dorsal root ganglion neurons of the rat via Y2 receptor. Br J Pharmacol 103:1781–1789

    PubMed  CAS  Google Scholar 

  • Blessing WW, Howe PRC, Johi TH, Oliver JR, Willoughby JO (1986) Distribution of tyrosine hydroxylase and neuropeptide Y-like immunoreactive neurons in rabbit medulla oblongata with attention to colocalizaiton studies, presumptive adrenaline containing perikarya ad vagal preganglionic cells. J Comp Neurol 248:285–300

    PubMed  CAS  Google Scholar 

  • Blessing WW, Oliver JR, Hodgson AJ, Joh TH, Willoughby JO (1987) Neuropeptide Y-like immunoreactive CI neurons in the rostral ventrolateral medulla of the rabbit projects to sympathetic preganglionic neurons in the spinal cord. J Aut Nerv Syst 18:121–129

    CAS  Google Scholar 

  • Boehm S, Huck S (1997) Receptors controlling transmitter release from sympathetic neurons in vitro. Program Neurobiol 51:225–242

    CAS  Google Scholar 

  • Boehm S and Kubista H (2002) Fine tuning of sympathetic transmitter release via inotropic and metabutropic presynaptic receptors. Pharmacol Rev 54:43–99

    PubMed  CAS  Google Scholar 

  • Bohmann C, Rump LA Schaible U, von Kugelgen I (1995) α-Adrenoceptor modulation of norepinephrine and ATP release in isolated kidneys of spontaneously hypertensive rats. Hypertension 25:1224–1231

    PubMed  CAS  Google Scholar 

  • Bradley E, Law A, Bell D, Johnson CD (2003) Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery. Am J Physiol Heart Circ Physiol 284:H2007–H2014

    PubMed  CAS  Google Scholar 

  • Bulloch JM, Starke K (1990) Presynaptic α2-autoinhibition in a vascular neuroeffector junction where ATP and noradrenaline act as co-transmitters. Br J Pharmacol 99:279–284

    PubMed  CAS  Google Scholar 

  • Bultmann R, Von Kugelgen I, Starke K (1991) Contraction-mediating α-adrenoceptors in the mouse vas deferens. Naunyn-Schmiedeberg’s Arch Pharmacol 343:623–632

    CAS  Google Scholar 

  • Burnstock G (1999) Purinergic cotransmission. Brain Res Bull 50:355–357

    PubMed  CAS  Google Scholar 

  • Burnstock G, Warland JJT (1987) A pharmacological study of the rabbit saphenous artery in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation. Br J Pharmacol 90:111–120

    PubMed  CAS  Google Scholar 

  • Burnstock G, Campbell G, Satchell D, Smythe A (1970) Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40:668–688

    PubMed  CAS  Google Scholar 

  • Cao GH, Westfall TC (1993) Effects of dopamine agonists on the release of neuropeptide Y immunoreactivity from the nucleus accumbens and striatum of rat brain. Soc Neurosci Abs 19:1173

    Google Scholar 

  • Cao GH, Houston D, Westfall TC (1995) Mechanism underlying dopamine receptor mediated inhibition of neuropeptide Y release from pheochromocytoma cells. Soc Neurosci Abs 21:1378

    Google Scholar 

  • Cao GH, Westfall TC (1995) Dopamine D2 receptor-mediated inhibitio of neuropeptide Y (NPY) release from pheochromocytoma (PC12) cells. Physiologist 38(5):A260

    Google Scholar 

  • Changeux JP (1986) Coexistence of neuronal messengers and molecular selection. Prog Brain Res 63:373–403

    Google Scholar 

  • Chen G, von den Pol AN (1996) Multiple NPY receptors coexist in pre-and postsynaptic sites: Inhibition of GABA release in isolated self-innervating SCN neurons. J Neurosci 16:7711–7724

    PubMed  CAS  Google Scholar 

  • Chen X, Westfall TC (1994) Modulation of intracellular calcium transients and dopamine release by neuropeptide Y in PC12 cells. Am J Physiol 266 (Cell Physiol 35):C784–C793

    PubMed  CAS  Google Scholar 

  • Chen X, DiMaggio D, Han S-P, Westfall TC (1997) Autoreceptor induced inhibition of neuropeptide Y release from PC 12 cells is mediated by Y2 receptors. Am J Physiol 273 (Heart Circ Physiol 42):H1737–1744

    PubMed  CAS  Google Scholar 

  • Chernaeva L and Charakchieva S (1988) Leucine-enkephalin-and neuropeptide Y-modulation of (3H)-noradrenaline release in the oviduct of mature and juvenile rabbits. Gen Pharmacol 19:137–142

    PubMed  CAS  Google Scholar 

  • Chesselet MF (1984) Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience 12:347–375

    PubMed  CAS  Google Scholar 

  • Chronwall BM (1989) Anatomical distribution of NPY and NPY messenger RNA in rat brain. In: Mutt V, HöKfelt T, Fuxe K, Lundberg J (eds) Neuropeptide Y. Raven Press, New York, pp 51–60

    Google Scholar 

  • Chromwall BM, Chase TN, O’donohue T (1984) Coexistence of neuropeptide Y with somatostatin in rat and human cortical and rat hypothalamic neurons. Neurosci Lett 52:213–217

    Google Scholar 

  • Ciarleglio A, Bienfeld MC, Westfall TC (1993) Pharmacological characterization of the release of neuropeptide Y-like immunoreactivity from the rat hypothalamus. Neuropharmacol 8:819–825

    Google Scholar 

  • Colmers WB, Lukowiak K, Pittman QJ (1985) Neuropeptide Y reduces orthodromically evoked population spike in rat hippocampal CA1 by a possibly presynaptic mechanism. Brain Res 346:404–408

    PubMed  CAS  Google Scholar 

  • Colmers WF, Bleakman D (1994) Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci 17:373–379

    PubMed  CAS  Google Scholar 

  • Colmers WF, Klapstein GJ, Fournier A, St-Pierre S, Treherne KA (1991) Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br J Pharmacol 102:41–44

    PubMed  CAS  Google Scholar 

  • Colmers WF, Lukowiak K, Pittmann QJ (1988) Neuropeptide Y action in the hippocampal slice: site and mechanism of presynaptic inhibition. J Neurosci 8:3827–3837

    PubMed  CAS  Google Scholar 

  • Cortes V, Donoso MV, Brown N, Fanjul R, Lopez C, Fournier A, Huidobro-Toro JP (1999) Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs and BIBP 3226. J Pharm Exp Ther 289:1313–1322

    CAS  Google Scholar 

  • Cox CL, Huguenard JR, Prince DA (1995) Cholecystokinin depolarizes rat thalamic reticular neurons by suppressing a K+ conductance. J Neurophysiol 74:990–1000

    PubMed  CAS  Google Scholar 

  • Cox CL, Huguenard JR, Prince DA (1997) Peptidergic modulation of intrathalamic circuit activity in vitro actions of cholecytokinin. J Neurosci 17:70–82

    PubMed  CAS  Google Scholar 

  • Dahlöf C (1981) Studies on β-adrenoceptor mediated facilitation of sympathetic neurotransmission. Acta Physiol Scand Suppl 500:1–147

    PubMed  Google Scholar 

  • Dahlöf C, Dahlöf P, Tatemoto K, Lundberg JM (1985) Neuropeptide Y (NPY) reduces field stimulation evoked release of noradrenaline and enhances force of contraction in the rat portal vein. Naunyn Schmiedeberg’s Arch Pharmacol 328:327–330

    Google Scholar 

  • Dahlöf C, Dahlöf P, Lundberg JM (1986) α2-adrenerceptor mediated inhibition of nerve stimulation evoked release of neuropeptide Y immunoreactivity in the pithed guinea pig. Eur J Pharmacol 131:279–283

    PubMed  Google Scholar 

  • Dahlöf PL (1989) Modulatory interactions of neuropeptide Y on sympathetic neurotransmission. Acta Physiol Scand Suppl 586:1–85

    Google Scholar 

  • Dahlöf P, Lundberg JM, Dahlöf C (1991a) α-and β-adrenoceptor mediated effects of nerve stimulation evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig. J Auton Nervous System 35:199–210

    Google Scholar 

  • Dahlöf P, Lundberg JM, Dahlöf C (1991b) Effect of angiotensin II and captopril on plasma levels of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig. Neuropeptides 18:171–180

    PubMed  Google Scholar 

  • DeDeyn PP, Pickut BA, Vorzwijvelen A, D’Hodge A, Annart W, DePotter WP (1989) Subcellular distribution and axonal transport of noradrenaline, dopamine β hydroxylase and neuropeptide Y in dog splenic nerve. Neurochem Int 15:39–47

    CAS  Google Scholar 

  • DeQuidt ME, Richardson PJ, Emson PC (1985) subcellular distribution of neuropeptide Y like immunoreactivity in guinea pig neocortex. Brain Res 335:354–359

    CAS  Google Scholar 

  • DiMaggio DA, Farah JM, Westfall TC (1995) Effects of differentiation on neuropeptide receptors and response in pheochromocytoma cells. Endocrinol 134:719–721

    Google Scholar 

  • Donoso MV, Steiner M, Huidobro-Toro JP (1997) BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine-5’-triphosphate and noradrenaline as sympathetic cotransmitter in the rat arterial mesenteric bed. J Pharmacol Exp Ther 282:691–698

    PubMed  CAS  Google Scholar 

  • Doods H, Balda W, Wieland HA, Dollinger H, Schnorrenberg G, Essen T, Engel W, Eberlein W, Rudolf K (1999) BIIE 0246: a selective and high affinity neuropeptide Y Y2 receptor antagonist. Eur J Pharmacol 384:R3–R5

    PubMed  CAS  Google Scholar 

  • Driessen B, Von Kugelgen I, Starke K. (1994) Prpurinoceptor mediated modulation of neural noradrenaline and ATP release in guinea pig vas deferens. Naunyn-Schmiedeberg’s Arch Pharmacol 350:42–48

    CAS  Google Scholar 

  • Driessan B, Von Kugelgen I, Starke K (1993) Neural ATP release and its α2 adrenoceptor mediated modulation in guinea pig vas deferens. Naunyn-Schmideberg’s Arch Pharmacol 348:358–366

    Google Scholar 

  • Drumheller A, Bouoli SM, Fournier A, St-Pierre S, Jolicoeur FB (1994) Neurochemical effects of neuropeptide Y and NPY 2–36. Neuropeptides 27:271–296

    Google Scholar 

  • Dumont Y, Cadienx A, Doods H, Pheng LH, Abounader R, Hamel E, Jaquqes D, Regole D, Quirion R (2000) BIIE 0246 — A potent and highly selective non-peptide neuropeptide Y Y2 antagonist. Br J Pharmacol 129:1075–1088

    PubMed  CAS  Google Scholar 

  • Eccles JC (1986) Chemical transmission and Dale’s principle. Prog Brain Res 68:3–13

    PubMed  CAS  Google Scholar 

  • Edvinsson L, Ekblad E, Hadanson R, Wahlestedt C (1984) Neuropeptide Y potentiates the effects of various vasoconstrictor agents in rabbit blood vessels. Br J Pharmacol 83:519–525

    PubMed  CAS  Google Scholar 

  • Edvinsson L, Emson P, McCulloch J, Tatemoto K, Uddman R (1983) Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett 43:79–84

    PubMed  CAS  Google Scholar 

  • Ewald DA, Sternweis PC, Miller RJ (1988) Guamine nucleotide-binding protein Co induced coupling of neuropeptide Y receptors to Ca2+ channels in sensory neurons. Proc Natl Acad Sci USA 85:3633–3637

    PubMed  CAS  Google Scholar 

  • Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Hakanson R, Sundler F (1984) Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 8:225–235

    PubMed  CAS  Google Scholar 

  • Elliott TR (1904) On the action of adrenalin. J Physiol (Lond) 31:20–31

    Google Scholar 

  • Ellis Y, Davies JA (1994) The effects of neuropeptides on the release of neurotransmitter amino acids from rat striatum. Neuropeptides 26:65–69

    PubMed  CAS  Google Scholar 

  • Ellis JL, Burnstock G (1990) Neuropeptide Y neuromodulation of sympathetic co-transmission in the guinea pig vas deferens. Br J Pharmacol 100:457–462

    PubMed  CAS  Google Scholar 

  • Ellis JL, Burnstock G (1989) Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea pig vas deferens. Br J Pharmacol 97:1157–1164

    PubMed  CAS  Google Scholar 

  • Euler USv (1946) A specific sympathomimetic ergone in adrenergic nerve fibers (sympathetic) and its relationship to adrenaline and noradrenaline. Acta Physiol Scand 12:73–97

    Google Scholar 

  • Euler USv (1972) Synthesis, uptake and storage of catecholamines in adrenergic nerves. The effect of drugs. In: Blaschko H, Muschull E (eds) Catecholamine. Handbook of Experimental Pharmacology vol 33. Springer, Berlin, pp 186–230

    Google Scholar 

  • Everitt BJ, Hökfelt T (1989) The coexistence of neuropeptide Y with other peptides and amines in the central nervous system. In: Mutt V, Hökfelt T, Fuxe K, Lundberg JM (eds) Neuropeptide Y pp 61–71

    Google Scholar 

  • Fisher-Colbrie R, Diez-Guerra J, Emson PC, Winkler H (1986) Bovine chromaffin granules: immunological studies with antisera agonist NPY, Met-enkephalin and bombesin. Neuroscience 18:167–174

    Google Scholar 

  • Foucart S, Bleakman D, Bindokas VP, Miller RJ (1993) Neuropeptide Y and pancreatic polypeptide reduce calcium currents in acutely dissociated neurons from adult rat superior cervical ganglia. J Phrmacol Exp Ther 265:903–909

    CAS  Google Scholar 

  • Franco-Cereceda A, Lundberg JM, Dahlof D (1985) Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone. Acta Physiol Scand 124:361–369

    PubMed  CAS  Google Scholar 

  • Franco-Cereceda A, Sarra A, Lundberg JM (1989) Differential release of calcitonin-gene related peptide and neuropeptide Y from the isolated heart by capsaicin, ischemia, nicotine, bradykinin and oubain. Acta Physiol Scand 135:173–187

    PubMed  CAS  Google Scholar 

  • Francois-Bellan A, Kachidian P, Dusticier G, Tonon MC, Vaudry H, Bosler O (1990) GABA neurons in the rat suprachismatic nucleus: involvement in chemospecific synaptic circuitry and evidence for GAD-peptide colocalization. J Neurocytol 19:937–947

    PubMed  CAS  Google Scholar 

  • Fried G (1981) Small noradrenergic vesicles isolated from rat vas deferens biochemical and morphological characterization. Acta Physiol Scand (Suppl)493:1–25

    Google Scholar 

  • Fried G, Terenius L, Hokfelt T, Goldstein M (1985b) Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens. J Neurosci 5:440–458

    Google Scholar 

  • Fried G, Lundberg JM, Theodorsson-Norheim E (1985a) Subcellular storage and axonal transport of neuropeptide Y in relation to catecholamines in the cat. Acta Physiol Scand125:145–154

    PubMed  CAS  Google Scholar 

  • Fuder H, Muscholl E (1995) Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves. Rev Physiol Biochem Pharmacol 126:265–412

    PubMed  CAS  Google Scholar 

  • Funess JB, Costa M, Emson PD, Hakanson R, Moghimzadeh E, Sunder F, Taylor IL, Chance RE (1983) Distribution pathways and reactions to drug treatment of nerves with neuropeptide Y and pancreatic polypeptide like immunoreactivity in the guinea pig digestive tract. Cell Tiss Res 234:71–92

    Google Scholar 

  • Furtinger J, Pirker S, Czech T, Baumgartner C, Ransmayr G, Sperk G (2001) Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 21:5804–5812

    PubMed  CAS  Google Scholar 

  • Gehlert DR, Beavers LS, Johnson O, Gackenheimer S, Schober DA, Gadski A (1996) Expression cloning of a human brain neuropeptide Y2 receptor. Mol Pharmacol 49:224–228

    PubMed  CAS  Google Scholar 

  • Gerald C, Walker MW, Criscione L, Gustofson EL, Batzl-Hartman C, Hofbauer KG, Tober RI, Branchek TA, Weinshank RL (1996) A receptor subtype involved in neuropeptide Y induced food intake. Nature 382:168–171

    PubMed  CAS  Google Scholar 

  • Gillespie JS (1980) Presynaptic receptors in the autonomic nervous system. In: Szekers L (ed) Adrenergic activators and inhibitors. Handbook of experimental pharmacology vol 54. Springer-Verlag Berlin, pp 353–425

    Google Scholar 

  • Greber S, Schwarzer C, Sperk G (1994) Neuropeptide Y inhibits potassium stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br J Pharmacol 113:737–740

    PubMed  CAS  Google Scholar 

  • Gregor P, Feng Y, DeCarr LB, Cornfield LJ, McCalebi ML (1996) Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J Biol Chem 271:2776–27781

    Google Scholar 

  • Grouzmann E, Bucling T, Martire M, Cannizzaro C, Dorner B, Razaname A, Mutter M (1997) Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. J Biol Chem 272:7699–7706

    PubMed  CAS  Google Scholar 

  • Grundamar L, Widmark E, Waldesk B, Hakamson R (1988) Neuropeptide Y: prejunctional inhibition of vagally induced contraction in the guinea pig trachea. Regul Pept 23:309–313

    Google Scholar 

  • Grundamer L, Grundstrom N, Johansson IGM, Andersson RCG, Hakasson R (1990) Suppression by NPYof capsasin-sensitive sensory nerve-mediated contractions in guinea pig air ways. Br J Pharm 99:473–476

    Google Scholar 

  • Haas HL, Herman A, Greene RW, Chan-Palay V (1987) Action and location of neuropeptide tyrosine (Y) on hippocampal neurons of the rat in slice preparations. J Comp Neurol 257:208–215

    PubMed  CAS  Google Scholar 

  • Haass M (1989) Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of NA and NPY in guinea pig heart. Naunyn-Schmiedeberg’s Arch Pharmacol 339:71–78

    CAS  Google Scholar 

  • Haass M, Hock M, Richardt G, Schöming A (1989a) NPY differentiates between exocytoxic and nonexocytotic NA release in guinea pig heart. Naunyn-Schmiedeberg’s Arch Pharm 340:509–515

    CAS  Google Scholar 

  • Haass M, Cheng B, Richardt G, Lang RE, Schöming H (1989b) Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart. Naunyn-Schmiedeberg’s Arch Pharmacol 339:71–78

    CAS  Google Scholar 

  • Hafstrand A, Fuxe K, Terenius L, Kalla M (1987) Neuropeptide Y-immunoreactive perikarya and rat nerve terminals in the rat medulla oblongata relationship to cytoarchitecture and catecholaminergic cell groups. J Comp Neurol 260:20–35

    Google Scholar 

  • Hall GT, Potter EK (1988) Alpha-adrenoceptor mediated modulation of sympathetic effects on the action of the vagus nerve at the heart. Neurosci Lett 30(Suppl): S70

    Google Scholar 

  • Hammond JR, MacDonald WF, White TD (1988) Evoked secretion of (3H)noradrenaline and ATP from nerve varicosities isolated from the myenteric plexus of the guinea pig ileum. Can J Physiol Pharmacol 66:560–575

    Google Scholar 

  • Han S-P, Yang, C-L, Chen X, Naes L, Cox BF, Westfall TC (1998a) Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation induced vasoconstriction. Am J Physiol 274 (Heart Circ Physiol 43):H290–294

    PubMed  CAS  Google Scholar 

  • Han S-P, Chen X, Cox B, Yang C-L, Wu YM, Naes L, Westfall TC (1998b) Role of neuropeptide Y in cold stress induced hypertension. Peptides 19:351–358

    PubMed  CAS  Google Scholar 

  • Hasting JA, McClure-Sharp JM, Morris MJ (2001) NPY Y1 receptors exert opposing effects in corticotropin releasing factor and noradrenaline overflow from rat hypothalamus in vitro. Brain Res 890:32–37

    Google Scholar 

  • Hastings JA, Pavia JM, Morris MJ (1997) Neuropeptide Y and [Leu31,Pro34] neuropeptide Y potentiate potassium induced noradrenaline release in the paraventricular nucleus of the aged rat. Brain Res 750:301–304

    PubMed  CAS  Google Scholar 

  • Heilig M, Vecsul L, Wahlestedt C, Ailing C, Widerlov E (1990) Effects of centrally administered neuropeptide Y and NPY 13–36 on the brain monoaminergic system of the rat. J Neural Tran 79:193–208

    CAS  Google Scholar 

  • Hendry SH, Jones EG, DeFelipe J, Schmechel P, Brandon C, Emson PC (1984) Neuropeptide containing neurons of the cerebral cortex are also GABAergic. Proc Natl Acad Sci USA 81:6526–6530

    PubMed  CAS  Google Scholar 

  • Hendry SHC (1993) Organization of neuropeptide Y neurons in the mammalian central nervous system. In: Colmers WF, Wahlestedt C (eds) The biology of Neuropeptide Y and related peptides. Humana Press, Totowa, pp 65–156

    Google Scholar 

  • Hirning LA, Fox AP, Miller RJ (1990) Inhibition of calcium currents in cultured myenteric neurons by neuropeptide Y: evidence for direct receptor/channel coupling. Brain Res 532:120–130

    PubMed  CAS  Google Scholar 

  • Hoang D, Macarthur H, Gardner A, Westfall TC (2002) Endothelin induced modulation of neuropeptide Y and norepinephrine release from the rat mesenteric bed. Am J Physiol Heart Circ Physiol 283:H1523–H1530

    PubMed  CAS  Google Scholar 

  • Hoang D, Macarthur H, Gardner A, Yang C-L, Westfall TC (2003) Prostanoid induced modulation of neuropeptide Y and noradrenaline release from the rat mesenteric bed. Autonomic and Autacoid Pharmacol 23:141–147

    CAS  Google Scholar 

  • Hokfelt T, Lundbert JM, Lagercrantz H, Tatemoto K, Mutt V, Lindberg J, Terenius L

    Google Scholar 

  • Everitt B, Fuxe K, Agnati L, Goldstein M (1983a) Occurrence of neuropeptide Y-like immunoreactivity in catecholamine neurons in the human medulla oblongata. Neurosci Lett 36:217–222

    PubMed  Google Scholar 

  • Hokfelt T, Lundberg JM, Tatemoto K, Mutt V, Terenius L, Polak J, Blooms Sasek C, Elde R, Goldstein M (1983b) Neuropeptide Y and FMRF amide neuropeptide like immunoreactivities in catecholamine neurons of the rat medulla oblongata in catecholamine neurons of the rat medulla oblongata. Acta Physiol Scand 117:315–318

    PubMed  CAS  Google Scholar 

  • Holton FA, Holton P (1954) The capillary dilator substance in dry powders of spinal roots: a possible role of adenosine triphosphate in chemical transmission from nerve endings. J Physiol (Lond) 126:124–140

    CAS  Google Scholar 

  • Hoyo Y, McGrath JC and Vila E (2000) Evidence for Y1-receptor mediated facilitatory, modulatory cotransmission by NPY in the rat anoccygeus muscle. J Pharm Exp Ther 294:38–44

    CAS  Google Scholar 

  • Illes P, Finta EP, Nieber (1993) Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurons. Naunyn Schmiedeberg’s Arch Pharmacol 348:546–548

    CAS  Google Scholar 

  • Jonsson G (1983) Chemical lesioning techniques, monoamine neurotoxins In: Bjorkland A, Hökfelt J (eds) Methods in chemical neuroanatomy, vol. 1 Elsevier, Amsterdam, pp 463–507

    Google Scholar 

  • Kahan T, Pernow J, Schwieler J, Lundberg JM, Hjemdahl P, Wallin BG (1988) Involvement of neuropeptide Y in sympathetic vascular control of skeletal muscle in vivo. J Hypertens 6(Suppl)4:532–534

    Google Scholar 

  • Kasakov L, Ellis J, Kirkpatrick K, Milner P, Burnstock (1988) Direct evidence for the concomitant release of noradrenaline, adenosine 5’-triphosphate and neuropeptide Y from sympathetic nerves supplying the guinea pig vas deferens. J Auton Nerv System 22:75–82

    CAS  Google Scholar 

  • Kawasaki H, Nuki C, Sauto A, Takasaki K (1991) NPY modulates neurotransmission of CGRP-containing vasodilator nerves in rat mesenteric arteries. Am J Physiol 261:H683–690

    PubMed  CAS  Google Scholar 

  • Kerkerian L, Bosler O, Pelletier G, Nieouillon A (1986) Striatal neuropeptide Y neurons are under the influence of the nigrostriatal dopamine pathway: immunohistochemical evidence. Neurosci Lett 66:106–112

    PubMed  CAS  Google Scholar 

  • Kerkerian L, Le-Goff L, Forni C, Samuel D, Bloc A (1992) Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in rat striatum. Brain Res Bull 28:187–193

    Google Scholar 

  • Kilborn MJ, Potter KA, McCloskey DJ (1986) Effects of periods of conditioning stimulation and of neuropeptides on vagal action at the heart. J Auton Nervous System 17:131–142

    CAS  Google Scholar 

  • King PJ, Williams G, Doods H, Widdowson PS (2000) Effect of a selective neuropeptide Y Y2 receptor antagonist BIIE 0246 on neuropeptide Y release. Eur J Pharmacol 396:1–3

    Google Scholar 

  • King PJ, Widdowson PS, Doods HN, Williams G (1999) Regulation of neuropeptide Y release by neuropeptide Y ligands and calcium channel antagonists in hypothalamic slices. J Neurochem 73:641–646

    PubMed  CAS  Google Scholar 

  • Klapstein G, Colmers WF (1997) Neuropeptide Y suppresses epileptic-form activity in rat hippocampus in vitro. J Neurophysiol 76:1651–1661

    Google Scholar 

  • Klapstein GJ, Conners WF (1993) On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus 3:103–111

    PubMed  CAS  Google Scholar 

  • Klein RL (1982) Chemical composition of the large noradrenergic vesicles. In: Klein RL, Lagercrantz H, Zimmermann H (eds) Neurotransmitter vesicles. Academic Press, London pp. 133–174

    Google Scholar 

  • Koelle GB (1955) The histochemical identification of acetylcholinesterase in cholinergic, adrenergic and sensory neurons. J Pharmacol Exp Ther 114:167–184

    PubMed  CAS  Google Scholar 

  • Kohler C, Ericksson LG, Davies S, Chan-Palay V (1986) Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J Comp Neurol 244:384–400

    PubMed  CAS  Google Scholar 

  • Kotecha N (1998) Modulation of submucosal arterilar tone by NPY-Y2 receptors in the guinea pig-small intestine. J Auton Ner Sys 70:157–163

    CAS  Google Scholar 

  • Krause J, Eva C, Seeburg PH and Sprengel R (1992) Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol Pharmacol 41:817–821

    PubMed  CAS  Google Scholar 

  • Kuramoto H, Kondo H, Fujita T (1986) Neuropeptide tyrosine like-immunoreactivity in adrenal chromaffin cells and intradrenal nerve fibers of rats. Anat Rec 214:321–328

    PubMed  CAS  Google Scholar 

  • Lacroix JS, Lundberg JM (1989) Adrenergic and neuropeptide Y supersensitivity in denervated nasal mucosa vasculature of the pig. Eur J Pharmacol 169:125–136

    PubMed  CAS  Google Scholar 

  • Lacroix JS, Stjärne L, Anggard A, Lundberg JM (1988) Sympathetic vascular control of the pig nasal mucosa (2): Reserpine-resistant, non-adrenergic nervous responses in relation to neuropeptide Y and ATP. Acta Physiol Scand 133:183–197

    PubMed  CAS  Google Scholar 

  • Lacroix JS, Ulman LG, Potter EK (1994) Modulation by neuropeptide Yof parasympathetic nerve-evoked nasal vasodilation by Y2 prejunctional receptor. Br J Pharmacol 113:479–484

    PubMed  CAS  Google Scholar 

  • Lacroix J-S (1989) Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol Scand (Suppl) 581:1–63

    CAS  Google Scholar 

  • Lagercrantz H (1971) Isolation and characterization of sympathetic nerve trunk vesicles. Acta Physiol Scand (Suppl) 82366)1–40

    Google Scholar 

  • Lagercrantz H, Fried G (1982) Chemical Composition of the Small Noradrenergic Vesicles. In: Klein RL, Lagercrantz H, Zimmermann H (eds) Neurotransmitter vesicles. Academic, London, pp 175–188

    Google Scholar 

  • Laher I, Germann P, Bevan J A (1994) Neurogenecally evoked cerebral artery constriction is mediated by neuropeptide Y. Can J Physiol Pharm 72:1086–1088

    CAS  Google Scholar 

  • Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337–362

    Google Scholar 

  • Langer SZ (1997) 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol Sci 18:95–99

    PubMed  CAS  Google Scholar 

  • Langer SZ, Lehmann J (1988) Presynaptic receptors on catecholamine neurons. In: Catecholamines. DeHandbook of Experimental Pharmacology vol 85. Trendelenbury IU, Werner N (eds) Springer-Verlag, Berlin pp 419–507

    Google Scholar 

  • Larhammar L, Bloomqvist AG, Yee F, Jasin E, Yoo H, Wahlestedt C (1992) Cloning and functional expression of human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem 267:10935–10938

    PubMed  CAS  Google Scholar 

  • Levitt B, Head RJ, Westfall DP (1984) High pressure chromatographic flurometric detection of adenosine and adenosine nucleosides: application to endogenous content and electrically induced relese of adenylpurines in guinea pig vas deferens. Anal Biochem 137:93–100

    PubMed  CAS  Google Scholar 

  • Linial M, Ilouz N, Parnas H (1997) Voltage-dependent interaction between the muscarinic ACh receptor and proteins of the exocytic machinery. J Physiol 504:251–258

    PubMed  CAS  Google Scholar 

  • Loewi O (1921) Uer Lumorale Ubertregbarkeit dere Herznervenwirkung. Pflügers Arch 189:239–242

    Google Scholar 

  • Loewi O (1936) Quantitative and qualitative Untersuchungen über der sympathicusstoff. Zugleich XIV Mittüber humorale Ubertragbarkait der Herznervenwirkung. Pflügers Arch 237:504–514

    CAS  Google Scholar 

  • Lundberg, JM, Pernow J, Franco-Cereceda A, Rudehill A (1987) Effects of antihypertensive drugs on sympathetic vascular control iln relation to NPY. J Card Pharm 10(Suppl 12):551–568

    Google Scholar 

  • Lundberg JM (1996) Pharmacology of cotransmission in the autonomic nervous system: interactive aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48:113–178

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Modin A (1995) Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226. Br J Pharmacol 116:2971–2982

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Tatemoto K (1982) Pancreatic polypeptide family (APP, BPP, NPY, PYY) in relation to sympathetic vasoconstriction resistant to α-adrenoceptor blockade. Acta Physiol Scand 116:393–402

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Anggard A, Theodorsson Norheim E, Pernow J (1984a) Guanethidine-sensitive release of NPY-Li in the cat spleen by sympathetic nerve stimulation. Neurosci Lett 52:175–180

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Hua X-Y, Franco-Cereceda A (1984b) Effects of neuropeptide Y mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea pig. Acta Physiol Scand 121:325–332

    PubMed  CAS  Google Scholar 

  • Lundberg M nad Stjärne L (1984) Neuropeptide Y depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation of the rat vas deferens. Acta Physiol Scand 120:477–479

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Martinson A, Hemsen A, Theodorsson-Norheim E, Svederberg J, Ekblom E, Hjemdahl P (1985a) Corelease of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Comm 133:30–36

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Pernow J, Tatemoto K, Dahlof C (1985c) Pre-and postjunctional effects of NPY on sympathetic control of rat femoral artery. Acta Physiol Scand 123:511–513

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Rudehill A, Sollevi A (1989a) Pharmacological characterization of neuropeptide Y and noradrenaline mechanisms in sympathetic control of pig spleen. Eur J Pharmacol 163:103–113

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Rudehill A, Sollevi A, Hamberger B (1989c) Evidence for co-transmitter role of neuropeptide Y in the pig spleen. Br J Pharmacol 96:675–687

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Rudehill A, Sollevi A, Fried G, Wallin G (1989b) Co-release of neuropeptide Y an noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience 28:475–486

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Rudehill A, Sollevi A, Theodorosson-Norheim E, Hamberger B (1986) Frequency-and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett 63:96–100

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Saria A, Franco-Cereceda A, Theodorsson-Norheim E (1985d) Mechanisms underlying a change in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs. Acta Physiol Scand 124:603–611

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Terenus L, Hokfelt J, Martling C-R, Tatemoto K, Mutt V, Polak J, Bloom S, Goldstein M (1982) Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and the effects of NPY on sympathetic function. Acta Physiol Scand 116:477–480

    PubMed  CAS  Google Scholar 

  • Lundberg JM, Torssell L, Sollevi A, Pernow J, Theodorsson-Norheim E, Anggard A, Hamberger, B (1985b) Neuropeptide Y and sympathetic vascular control in man. Regul Pept 13:41–52

    PubMed  CAS  Google Scholar 

  • Lundblad L, Anggard A, Saria A, Lundberg JM (1987) Neuropeptide Y and non-adrenergic sympathetic vascular control of the cat nasal mucosa. J Auton Nerv Sys 20:188–197

    Google Scholar 

  • Lundell LA, Bloomqvist G, Berglung MM, Schober DA, Johnson D, Statnick MA, Gadake RA, Gehlert DR, Larbammar D (1995) Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem 270:29129–29128

    Google Scholar 

  • Lynch JW, Lemos VS, Buchner B, Stoclet JC, Takeda K (1994) A pertussis toxin-insensitive calcium influx mediated by neuropeptide Y receptors in a human neuroblstoma cell line. J Biol Chem 269:8226–8233

    PubMed  CAS  Google Scholar 

  • Maccarrone C, Jarrott B (1986) Neuropeptide Y: a putative neurotransmitter (critique). Neurochem Int 87:13–22

    Google Scholar 

  • Malmström RC, Lundberg JON, Weitzberg E (2002) Effects of the neuropeptide Y-Y2 receptor antagonists BIIE 0246 on sympathetic transmitter release in the pig in vivo. Naunyn-Schmiedeberg’s Arch Pharmacol 365:106–111

    Google Scholar 

  • Malmström RC (1997) Neuropeptide Y Y1 receptor mechanism in sympathetic vascular control. Acta Physiol. Scand Suppl 636:1–55

    Google Scholar 

  • Malmström RC, Modin A, Lundberg JM (1996a) SR 120107A antagonizes neuropeptide Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo. Eur J Pharmacol 305:145–154

    PubMed  Google Scholar 

  • Malmström RC, Balmer KC, Lundberg JM (1997) The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo. Br J Pharmacol 121:595–603

    PubMed  Google Scholar 

  • Malmström RC, Hokfelt T, Bjorkman JA, Nihlen C, Bystrom M, Ekstrand AJ, Lundberg JM (1998) Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog. Regul Pept 75–76, 55–70

    PubMed  Google Scholar 

  • Malmström RE (2001) Vascular pharmacology of BIIE 0246, the first selective non-peptide neuropeptide Y Y2 receptor antagonist in vivo. Br J Pharmacol 133:1073–1080

    PubMed  Google Scholar 

  • Malmström RE, Lundberg JM (1995a) Neuropeptide Y accounts for sympathetic vasoconstriction in guinea pig vena cava: evidence using BIBP 3226 and 3435. Eur J Pharmacol 294:661–668

    PubMed  Google Scholar 

  • Malmström RE, Lundberg JM (1995b) Endogenous NPY acting on Y1 receptors accounts for the long-lasting part of the sympathetic contraction in guinea pig vena cava: evidence using SR 120207A. Acta Physiol Scand 155:329–330

    PubMed  Google Scholar 

  • Malmström RE, Lundberg JM (1996b) Effects of the neuropeptide Y Y1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo. Naunyn Schmiedberg’s Arch Pharmacol 354:633–642

    Google Scholar 

  • Malmström RE, Alexandersson A, Balmer KC, Weilizt J (2000) In vivo characterization of the novel neuropeptide Y Y1 receptor antagonist H409/22. J Cardiovas Pharmacol 36:516–525

    Google Scholar 

  • Martire M, Pistritto G (1992) Neuropeptide Y interaction with the adrenergic transmission line: A study of its effect on alpha 2 adrenergic receptors. Pharmacol Res 25:203–215

    PubMed  CAS  Google Scholar 

  • Martire M, Fuxe K, Pistriffo P, Agnati LF (1986) Neuropeptide Y enhances the inhibitory effects of clonidine on 3H-noradrenaline release in synaptosomes isolated from the medulla oblongata of the male rat. J Neural Trans 67:113–124

    CAS  Google Scholar 

  • Martire M, Fuxe K, Pistritto G, Preziosi P, Agnati LF (1989a) DeNeuropeptide Y increased the inhibitory effects of clonidine on potassium evoked 3H-noradrenaline but not 3H-5 hydroxytryptamine release from synaptosomes of the hypothalamus and the frontoparietal cortex of the male Sprague Dawley rat. J Neural Trans 78:61–72

    CAS  Google Scholar 

  • Martire M, Fuxe K, Pistritto P, Agnati LF (1989b) Reduced inhibitory effects of clonidine and neuropeptide Y on 3H-noradrenaline release of the medulla oblongata of the spontaneously hypertensive rat. J Neural Tran 76:181–189

    CAS  Google Scholar 

  • Martire M, Pistritto G, Mores N, Agnati LF, Fuxe K (1993) Region specific inhibition of potassium evoked 3H-noradrenaline release from rat brain synaptosomes by neuropeptide Y 13–36: involvement of NPY receptors of the Y2 type. Eur J Pharmacol 230:231–234

    PubMed  CAS  Google Scholar 

  • Martire M, Pistritto G, Morris N, Agnati LF, Fuxe K (1995) Presynaptic A2 adrenoceptors and neuropeptide Y Y2 receptors inhibit 3H-noradrenaline release from rat hypothalamic synaptosomes via different mechanisms. Neurosci Lett 188:9–12

    PubMed  CAS  Google Scholar 

  • McAuley M, Westfall TC (1992) Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed. J Pharmacol Exp Ther 261:863–868

    PubMed  CAS  Google Scholar 

  • McCullough A, Westfall TC (1996) Mechanisms of catecholamine synthesis inhibition by neuropeptide Y: role of Ca2+ channels and protein kinases. J Neurochem 67:1090–1099

    PubMed  CAS  Google Scholar 

  • McCullough LA, Westfall TC (1995) Neuropeptide Y inhibits depolarization induced catecholamine synthesis in rat pheochromocytoma cells. Eur J Pharmacol 287:271–277

    PubMed  CAS  Google Scholar 

  • McCullough LA, Egan TM, Westfall TC (1998a) Neuropeptide Y receptors involved in calciuim channel regulation in PC12 cells. Regul Pept 75/76:101–107

    Google Scholar 

  • McCullough LA, Egan TM, Westfall TC (1998b) Neuropeptide Y inhibition of calcium channels in PC12 pheochromocytoma cells. (Cell Physiol)274 (Cell Physiol 43):C1290–C1297

    Google Scholar 

  • McDonald RL, Vaughan PFT, Beck-Sickinger AG, Peers C (1995) Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue. Neuropharmacol 34:1507–1514

    CAS  Google Scholar 

  • Miller RJ (1998) Presynaptic receptors. Ann Rev Pharmacol Toxicol 38:201–207

    CAS  Google Scholar 

  • Milner TA, Veznedaroglu E (1992) Ultrastructural localization of neuropeptide Y-like immunoreactivity in the rat hippocampal formation. Hippocampus 2:107–126

    PubMed  CAS  Google Scholar 

  • Modin A, Pernow J, Lundberg JM (1993) Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y. Acta Physiol Scand 148:1–11

    PubMed  CAS  Google Scholar 

  • Moriarity M, Potter EK, McCloskey DI (1993) Pharmacological seperation of cardio-accelerator and vagal inhibitory capacities of sympathetic nerves. J Auton Nerv System 43:7–16

    Google Scholar 

  • Morris BJ (1989) Neuronal localization of neuropeptide gene expression in rat brain. J Compet Neurol 290:358–368

    CAS  Google Scholar 

  • Morris JL (1991) Roles of neuropeptide Y and noradrenaline in sympathetic neurotransmission to the thoracic vena cava and aorta of guinea pig. Regul Pept 32:297–310

    PubMed  CAS  Google Scholar 

  • Morris JL, Gibbins IL (1992) Co-transmission and neuromodulation. In: Ed. Burnstock G, Hoyle CHV (eds) Autonomic neuroeffector mechanisms. Harwood Academic Publishers, Chur UK, pp 33–119

    Google Scholar 

  • Morris JL, Jobling P, Gibbins IL (2001) Differential inhibition by Botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am J Physiol (Heart Circ Physiol) 28LH2124–H2132

    Google Scholar 

  • Morris JL, Jobling P, Gibbins IL (2002) Botulinum neurotoxin A attenuates release of norepinephrine but not neuropeptide Y from vasoconstrictor nerves. Am J Physiol (Heart Circ Physiol) 283:H2627–H2635

    CAS  Google Scholar 

  • Moukhles H, Nieoullon A, Daszuta A (1992) Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon Cells. Neuroscience 47:781–792

    PubMed  CAS  Google Scholar 

  • Muramatsu I (1987) The effect of reserpine on sympathetic purinergic neurotransmission in the isolated mesenteric artery of the dog: a pharmacological study. Br J Pharmacol 91:467–474

    PubMed  CAS  Google Scholar 

  • Mutofova-Yambolieva VN, Westfall DP (1998) Inhibitory and facilitory presynaptic effects of endothelin on sympathetic co-transmission in the rat isolated tail artery. Br J Pharmacol 123:136–142

    Google Scholar 

  • Mutofova-Yambolieva VNM, Westfall DP (1995) Endothelin-3 can both facilitate and inhibit transmitter release in the guinea pig vas deferens. Eur J Pharmacol 285:213–216

    Google Scholar 

  • Norenberg W, Bek M, Limberger N, Takeda K, Hies K (1995) Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A septum. Naunyn Schmiedeberg’s Arch Pharmacol 351:337–347

    CAS  Google Scholar 

  • Öhlen A, Persson MG, Lindbom L, Gustafsson LE, Hedqvist P (1990) Nerve induced nonadrenergic vasoconstriction and vasodilation in skeletal muscle. Am J Physiol 258:H1334–H1338

    PubMed  Google Scholar 

  • Oellerich WF, Schwartz DD, Malik KU (1994) Neuropeptide Y inhibits adrenergic transmitter release in cultured rat superior cervical ganglion cells by restricting the availability of calcium through a pertussis toxin-sensitive mechanism. Neuroscience 60:495–502

    PubMed  CAS  Google Scholar 

  • Patrylo P, van der Pol AN, Spencer DD, Williamson A (1999) NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J Neurophysiol 82:470–483

    Google Scholar 

  • Pavia JM, Hastings JA, Morris MJ (1995) Neuropeptide Y potentiation of potassium induced noradrenaline release in the hypothalamic paraventricular nucleus of the rat in vivo. Brain Res 690:108–111

    PubMed  CAS  Google Scholar 

  • Pernow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, Pernow B. (1986a) Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 6:561–578

    PubMed  CAS  Google Scholar 

  • Pernow J (1988) Corelease and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control. Acta Physiol Scand Suppl 569:1–56

    Google Scholar 

  • Pernow J, Lundberg JM (1989a) Modulation of noradrenaline and neuropeptide Y release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors. Naunyn Schmiedeberg’s Arch Pharmacol 340:379–385

    CAS  Google Scholar 

  • Pernow J, Lundberg JM (1989b) Release and vasoconstrictor effects of neuropeptide Y in relation to nonadrenergic sympathetic control of renal blood flow in the pig. Acta Physiol Scand 136:507–517

    PubMed  CAS  Google Scholar 

  • Pernow J, Kahan J, Hjemdahl P, Lundberg JM (1988a) Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle. Acta Physiol Scand 132:43–50

    PubMed  CAS  Google Scholar 

  • Pernow J, Kahan T, Lundberg JM (1988b) Neuropeptide Y and reserpine resistant vasoconstriction evoked by sympathetic nerve stimulation in dog skeletal muscle. Br J Pharmacol 94:952–960

    PubMed  CAS  Google Scholar 

  • Pernow J, Saria A, Lundberg JM (1986b) Mechanisms underlying pre-and postjunctional effects of neuropeptide Y in sympathetic vascular control. Acta Physiol Scand 126:239–249

    PubMed  CAS  Google Scholar 

  • Petitto JM, Huang Z, McCarthy DB (1994) Molecular cloning of a NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites. N Neuroimmunol 54:81–86

    CAS  Google Scholar 

  • Pheng LH, Fournier A, Dumont Y, Quirion R, Regoli D (1997) The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y. Eur J Pharmacol 327:163–167

    PubMed  CAS  Google Scholar 

  • Plummer MR, Rittenhause A, Kanevsky M, Hess P (1991) Neurotransmitter modulation of calcium channels in rat sympathetic neurons. J Neurosci 11:2339–2348

    PubMed  CAS  Google Scholar 

  • Potter EK (1985) Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y? Neuorsci Lett 54:117–121

    CAS  Google Scholar 

  • Potter EK (1987c) Guanethidine blocks neuropeptide Y-like inhibitory action of sympathetic nerves on cardiac vagus. J Auton Nerv Syst 21:87–90

    PubMed  CAS  Google Scholar 

  • Potter EK (1987a) Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y. Neurosci Lett 83:101–106

    PubMed  CAS  Google Scholar 

  • Potter EK (1987b) Cardiac vagal action and plasma levels of neuropeptide Y following intravenous injection in the dog. Neurosci Lett 77:243–247

    PubMed  CAS  Google Scholar 

  • Potter EK (1991) Neuropeptide Yas an autonomic neurotransmitter. In:Bell, C (ed) Novel peripheral neurotransmitters. Pergamon Press, New York, pp 81–112

    Google Scholar 

  • Qian J, Colmers WF, Saggu P (1997) Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry. J Neurosci 7:8169–8177

    Google Scholar 

  • Racchi H, Irarrazabal MJ, Howard M, Moran S, Zalaquett R, Huidobro-Toro JP (1999) Adenosine 5′-triphosphatae and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein Br J Pharmacol 126:1175–1185

    PubMed  CAS  Google Scholar 

  • Revington M, Lacroix JS, Potter EK (1997) Sympathetic and parasympathetic interaction in vascular and secretory control of the nasal mucosa of the anesthetized dog. J Physiol 505:823–831

    PubMed  CAS  Google Scholar 

  • Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Koduknia K, Kiemzel B, Seethla B (1995) Cloning and functional expression of a cDNA enclosiong a human type 2 neuropeptide receptor. J Biol Chem 270:22661–22664

    PubMed  CAS  Google Scholar 

  • Rudehill A, Sollevi A, Franco-Cereceda A, Lundberg JM (1986) Neuropeptide Y (NPY) and the pig heart: release and coronary vasoconstrictor effects. Peptides 7:821–826

    PubMed  CAS  Google Scholar 

  • Rump LC, Riess M, Schwertfeger E, Michel ML, Bohmann C, Schollmeyer P (1997) Prejunctional neuropeptide Y receptors in human kidney and atrium. J Cardiovas Pharmacol 29:656–661

    CAS  Google Scholar 

  • Samuelson VE, Dalsgaard CJ (2985) Action and localization of neuropeptide Y in the human fallopian tube. Neurosci Lett 58:49–54

    Google Scholar 

  • Schlicker E, Grob G, Fink K, Claser T, Gothert M (1991) Serotonin release in the rat brain cortex is inhibited by neuropeptide-Y but not affected by ACTH-24, antiogensin II, bradykinin and delta sleep-inducing peptide. Nauyn Schmiedeberg’s Arch Pharmacol 343:117–122

    CAS  Google Scholar 

  • Schoups A, Saxena A, Tombeur K, DePotter WP (1988) Facilitation of the release of norepinephrine and neuropeptide Y by alpha 2 adrenoceptor blocking agents idazoxan an hydergene in the dog spleen. Life Sci 43:517–523

    Google Scholar 

  • Schwarzer C, Kofler N, Sperk G (1998) Upregulation of neuropeptide Y Y2 receptors in an animal model of temporal lobe epilepsy. Mol Pharmacol 53:6–13

    PubMed  CAS  Google Scholar 

  • Serfozo P, Bartfai T, Vizi ES (1986) Presynaptic effects of neuropeptide Y on 3H-noradrenaline and 3H-acetylcholine release. Regul Pept 16:117–123

    PubMed  CAS  Google Scholar 

  • Silinsky EM, vonKügelgen I, Smith A, Westfall DP (1998) Functions of extracellular nucleotides in peripheral and central neuronal tissues. In: Turner JT, Weisman GA, Fedan JS (eds) The P2 Nucleotide Receptors. Humana Press Inc., Totowa. pp 259–290

    Google Scholar 

  • Silva AP, Carvalho AP, Carvalho CM, Malva JO (2001) Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dendate gyrus. J Neurochem 79:286–296

    PubMed  CAS  Google Scholar 

  • Simonneaux V, Ouichou A, Craft C, Pevet P (1994) Presynaptic and postsynaptic effects of neuropeptide Y in the rat pineal gland. J Neurochem 62:2464–2471

    PubMed  CAS  Google Scholar 

  • Smialowska M, Legutko B (1990) Influence of reserpine administration on neuropeptide Y immunoreactivity in the locus coeruleus and caudate putamen nucleus of the rat brain. Neuroscience 36:411–415

    PubMed  CAS  Google Scholar 

  • Smialowska M, Legutko B (1992) Haloperidol induced increase in neuropeptide Y immunoreactivity in locus coeruleus of rat brain. Neuroscience 47:351–355

    PubMed  CAS  Google Scholar 

  • Smith AD (1979) Biochemical Studies of the Mechanism of Release. In: Paton DM (ed) The release of catecholamines from adrenergic neurons. Pergamon Press, New York, pp 1–15

    Google Scholar 

  • Smith-White MA, Hardy TA, Brock JA, Potter EK (2001) Effects of a selective neuropeptide Y-Y2 receptor antagonist BIIE0246 on Y2 receptors at peripheral neuroeffector junctions. Br J Pharmacol 132:861–868

    PubMed  CAS  Google Scholar 

  • Smith-White MA, Herzog H, Potter EK (2002) Role of neuropeptide Y Y2 receptors in modulation of cardiac parasympathetic neurotransmission. Regul Peptides 103:105–111

    CAS  Google Scholar 

  • Smith-White MA, Wallace D, Potter EK (1999) Sympathetic parasympathetic interactions in the heart in the anesthetized rat. J Auton Nervous System 75:171–175

    CAS  Google Scholar 

  • Smyth L, Bobalova J, Ward SM, Mutafova-Yambolieva VN (2000) Neuropeptide Y is a cotransmitter with norepinephrine in guinea pig inferior mesenteric vein. Peptides 21:835–843

    PubMed  CAS  Google Scholar 

  • Sneddon P (1995) Co-transmission. In: Powis DA, Bunn SJ (eds) Neurotransmitter release and its modulation. Cambridge University Press, Cambridge, pp 22–37

    Google Scholar 

  • Sneddon P, Westfall TC (1984) Pharmacological evidence that adenosine triphosphate and noradrenaline are cotransmitters in the guinea pig vas deferens. J Physiol (Lond) 347:561–580

    CAS  Google Scholar 

  • Sperlagh B, Vizi ES (1992) Is the neuronal ATP release from guinea-pig vas deferens subject to α-adrenoceptor mediated modulation? Neuroscience 51:203–209

    PubMed  CAS  Google Scholar 

  • Starke K (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124

    PubMed  CAS  Google Scholar 

  • Starke K (1981) Presynaptic receptors. Annu Rev Pharmacol Toxicol 21:7–30

    PubMed  CAS  Google Scholar 

  • Starke K (1987). Presynaptic a-autoreceptors. Rev Physiol Biochem Pharmacol 107:74–146

    Google Scholar 

  • Starke K, Gothert M, Kiblinger H (1989) Modulation of neurotransmitter release by presynaptic: receptors. Physiol Rev 69:865–989

    Google Scholar 

  • Stjärne L, Stjärne E, Mshgina M (1989) Does clonidine or neuropeptide Y-mediated inhibition of ATP secretion from sympathetic nerves operate primarily by increasing a potassium conductance? Acta Physiol Scand 136:137–138

    PubMed  Google Scholar 

  • Stjärne L (1964) Studies of catecholamine uptake, storage and release mechanisms. Acta Physiol Scand (Suppl) 64:1–228

    Google Scholar 

  • Stjärne L (1989) Basic mechanisms and local modulation of nerve impulse induced secretion of neurotransmitters from individual sympathetic nerve varicosities. Rev Physiol Biochem Pharmacol 112:1–137

    PubMed  Google Scholar 

  • Stjärne L, Lundberg JM, Astrand P (1986) Neuropeptide Y—a cotransmitter with noradrenaline and adenosine 5′-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience 18:151–166

    PubMed  Google Scholar 

  • Stjernquist M, Emson P, Owman C, Sjoberg N-O, Sander F, Tatemoto (1983) Neuropeptide Y in the female reproductive tract of the rat, distribution of nerve fibers and motor effects. Neurosci Lett 39:279–284

    PubMed  CAS  Google Scholar 

  • Stretton D, Miura M, Belvisi MG, Banes P (1992) Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves. Br J Pharmacol 93:672–678

    Google Scholar 

  • Sun L, Miller RJ (1999) Multiple NPY receptors regulate K+ and Ca2+ channels in acutely isolated neurons from the rat accuate nucleus. J Neurophysiol 81:1391–1403

    PubMed  CAS  Google Scholar 

  • Sun QQ, Akk G, Huguenard JR, Prince DA (2001) Differential regulation of GABA release and neuronal excitability mediated by neuropeptide Y1, and Y2 receptors in rat thalamic neurons. J Physiol 531:81–94

    PubMed  CAS  Google Scholar 

  • Sundler F, Böttcher G, Ekblad E, Häkanson R (1993) PP, PYY and NPY. Occurrence and distribution in the periphery. In: Colmers WF, Wahlestedt C (eds) The biology of neuropeptide Y and related peptides. Humana Press, Totowa, pp 157–196

    Google Scholar 

  • Tasuoka Y, Riskind PN, Beal MF, Martin JB (1987) The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleus. Brain Res 411:200–203

    Google Scholar 

  • Timmermans PBM, Thoolen WM (1987) Aulureceptors in the central nervous system. Med Res Rev 7:307–332

    PubMed  CAS  Google Scholar 

  • Todorov LD, Mihaylova-Todorova S, Grariso Gr, Bjur RA, Westfall TC (1996) Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea vas defrens. J Physiol 496:731–748

    PubMed  CAS  Google Scholar 

  • Todorov LK, Bjur RA, Westfall DP (1994) Temporal dissociation of the release of the sympathetic co-transmitters ATP and noradrenaline. Clin Exp Pharm Physiol 21:931–932

    CAS  Google Scholar 

  • Toth PT, Bindokas VP, Bleakman A, Colmers WF, Miller RJ (1993) Mechanism of presynaptic inhibitio nby neuropeptide Y at sympathetic nerve terminals. Nature 364:635–639

    PubMed  CAS  Google Scholar 

  • Tsuda J, Tsuda S, Goldstein M, Nishioi I, Masuyama Y (1992) Modulation of noradrenergic transmission by neuropeptide Y and presynaptic α2-adrenergic receptors in the hypothalamus of Spontaneously Hypertensive rats. Jap Heart J 33:229–238

    PubMed  CAS  Google Scholar 

  • Tsuda K, Tsuda S, Goldstein M, Masayama Y (1990) Effects of neuropeptide Y on norepinephrine levels in hypothalamic slices of Spontaneously Hypertensive rat. Eur J Pharm 182:175–179

    CAS  Google Scholar 

  • Tsuda K, Tsuda S, Nishioi I, Goldstein M, Masuyama Y (1997) Modulation of 3H-dopamine release by neuropeptide Y in rat Striatal slices. Eur J Pharmacol 321:5–11

    PubMed  CAS  Google Scholar 

  • Tsuda K, Yokou H, Goldstein M (1989) Neuropeptide Y and galanin in norepinephrine release in hypothalamic slices. Hypertension 14:81–86

    PubMed  CAS  Google Scholar 

  • Uddman R, Moller S, Nilson T, Nystrom S, Estrand J, Edvinsson L (2002) Neuropeptide Y Y1 and neuropeptide Y Y2 receptors in human cardiovascular tissue. Peptides 23:927–834

    PubMed  CAS  Google Scholar 

  • Vallejo M, Carter DA, Biswas S, Lightman SL (1987) Neuropeptide Y alters monoamine turnover in the rat brain. Neurosci Lett 73:155–160

    PubMed  CAS  Google Scholar 

  • Varndel IA, Polak TM, Allen JM, Terenghi G, Bloom SR (1984) Neuropeptide tyrosine immunoreactivity in norepinephrine containing cells and nerves of the mammalian adrenal gland. Endocrinology 114:1460–1462

    Google Scholar 

  • Vezzani A, Sperk G, Colmers WF (1999) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22:22–30

    Google Scholar 

  • Vizi S (1979). Presynaptic modulation of neurochemical transmission. Prog Neurobiol 12:181–292

    PubMed  CAS  Google Scholar 

  • vön Kügelgen I, Bultmann R, Starke K (1989) Effects of suramin and αβ-methylene ATP indicate noradrenaline-ATP co-transmission in the response of the mouse vas defer ens to single and low frequency pulses. Naunyn-Schmiedebergs Arch Pharmacol 340:760–763

    Google Scholar 

  • vön Kügelgen I (1996) Modulation of neural ATP release through presynaptic recepteors. Semin Neurosci 8:247–257

    Google Scholar 

  • Vuillet J, Kerkerian K, Salin P, Nieoullon A (1989) Ultrastructural features of NPY-containing neurons in the rat striatum. Brain Res 477:241–251

    PubMed  CAS  Google Scholar 

  • Wahestedt C, Edvisson E, Ekblad and Hakerson R (1987) Effects of neuropeptide Y at sympathetic neuroeffector junctions: Existence of Y1 and Y2 receptors In: Nobin A, Owens C (eds) Neuronal messengers in vascular function. Fernstrom Foundation Series vol 10. Elsevier, Amsterdam, pp 231–244

    Google Scholar 

  • Wahlestedt C, Karoum F, Jaskiw G, Wyatt RJ, Larhammar D, Ekman R, Reis DJ (1991) Cocaine induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. Proc Natl Acad Sci USA 88:2078–2082

    PubMed  CAS  Google Scholar 

  • Wahlestedt C, Yanihara N, Hakanson (1986) Evidence for different pre and postjunctional receptors for neuropeptide Y and related peptides. Regul Pept 13:307–318

    PubMed  CAS  Google Scholar 

  • Walker MW, Ewald DA, Perney TM, Miller RJ (1988) Neuropeptide Y modulates transmitter release and Ca2+ currents in rat sensory neurons. J Neurosci 8:2438–2446

    PubMed  CAS  Google Scholar 

  • Warland JJI, Burnstock G (1987) Effects of reserpine an 6-hydroxydopamine on the adrenergic and purinergic components of sympathetic nerve responses of the rabbit saphenous artery. Br J Pharmacol 92:871–880

    PubMed  CAS  Google Scholar 

  • Warner MR and Levy MN (1989a) Neuropeptide Y as a putative modulation of vagal effects on heart rate. Circ Res 64:882–889

    PubMed  CAS  Google Scholar 

  • Warner MR, Levy MN (1989b) Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y. Circ Res 65:1536–1546

    PubMed  CAS  Google Scholar 

  • Warner MR, Levy MN (1990) Role of neuropeptide Y in neural control of the heart. J Cardiovas Electrophysiol 1:80–91

    Google Scholar 

  • Warner MR, Senanayake P, Ferrario CM, Levy MN (1991) Sympathetic stimulationevoked overflow of norepinephrine and neuropeptide Y from the heart. CIRC Res 69:455–465

    PubMed  CAS  Google Scholar 

  • Weinberg DH, Sirinatainghji S, Tsu CP, Shiso LL, Morin N, Rigby MR, Heavens RH, Rapoport R, Bayne ML, Casclerl MA, Strader CD, Linemeyer DL, MacNeil BJ (1996) Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 271:16485–16488

    Google Scholar 

  • Weiser T, Wieland HA, Doods HN (2000) Effects of neuropeptide Y Y2 receptor antagonist BIIE 0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices. Eur J Pharmacol 404:133–136

    PubMed  CAS  Google Scholar 

  • Westfall DP, Todorov LD, Mihaylova-Todorova ST (2003) ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes. J Pharmacol Exp Ther 303:439–444

    Google Scholar 

  • Westfall DP, Dalzeil H, Forsyth K (1991) ATP as a neurotransmitter, cotransmitter and neuromodulator. In: Phillis J (ed) Adenosine and adenine nucleotides as regulators of cellular function. CRC Press Inc., Boca Raton, pp 295–305

    Google Scholar 

  • Westfall TD, Westfall DP (2001) Pharmacological techniques for the in vitro study of the vas deferens. J Pharmacol Toxicol Methods 45:109–122

    PubMed  CAS  Google Scholar 

  • Westfall TC (1980) Neuroeffector mechanisms. Annu Rev Physiol 42:383–397

    PubMed  CAS  Google Scholar 

  • Westfall TC (1990b) The physiological operation of presynaptic inhibitory autoreceptors. Ann NY Acad Sci 604:398–413

    PubMed  CAS  Google Scholar 

  • Westfall TC (1995) Beneficial therapeutic intervention via manipulation of presynaptic modulatory mechanisms In: Powis DA, Bunn SJ (eds) Neurotransmitter release and its modulation. Cambridge University Press, Cambridge, pp 328–346

    Google Scholar 

  • Westfall TC, Martin JR (1990) Presynaptic autoreceptors in the peripheral and central nervous system. In: Feigenbaum JJ, Hanani MM (eds) Presynaptic regulation of neurotransmitter release. Freund Publishing Co., London, pp 311–370

    Google Scholar 

  • Westfall TC, Carpentier S, Chen X, Beinfeld M, Naes L, Meldrum M (1987) Pre and postjunctional effects of neuropeptide Y at the noradrenergic neuroeffector junction of the perfused mesenteric arterial bed of the rat. J Cardiov Pharmacol 10:716–722

    CAS  Google Scholar 

  • Westfall TC, Han SP, Del Valle K, Curfman M, Ciarleglio A, Naes L (1990a) Presynaptic peptides an hypertension. NY Acad Sci 604:372–388

    CAS  Google Scholar 

  • Westfall TC, Martin J, Chen X, Ciarleglio A, Carpentier S, Henderson K, Knuepfer M, Beinfeld M, Naes L (1988) Cardiovascular effects and modulation of noradrenergic neurotransmission following central and peripheral administration of neuropeptide Y. Synapse 2:299–307

    PubMed  CAS  Google Scholar 

  • Westfall TC, Yang CL, Curfman-Falvey M (1995) Neuropeptide Y-ATP interactions at the vascular sympathetic neuroeffector junction. J Cardiol Pharmacol 26:682–687

    CAS  Google Scholar 

  • Westfall TC, Zhang S-Q, Carpentier S, Naes L, Meldrum J (1986) Local modulation of noradrenergic neurotransmission in blood vessels of normotensive and hypertensive animals. In: Margo A, Osswald A, Reis D, Vanhoutte P (eds) Central and peripheral mechanisms of cardiovascular regulation. Plenum Publishing, New York, pp 111–113

    Google Scholar 

  • Westfall TC (1977) Local regulation of adrenergic neurotransmission. Physiol Rev 57:659–728

    PubMed  CAS  Google Scholar 

  • Westfall TC, Chen X, Ciarleglio A, Henderson K, DelValle K, Curfman-Falvey M, Naes L (1990c) In vitro effects of neuropeptide Y at the vascular neuroeffector junction. Ann NY Acad Sci 611:145–155

    PubMed  CAS  Google Scholar 

  • Westfall TC, Peach MJ, Tittermary V (1979) Enhancement of the electrically induced release of norepinephrine from the rat portal vein: Modulation by beta2-adrenoceptors. Eur J Pharmacol 58:67–74

    PubMed  CAS  Google Scholar 

  • Whittaker E, Vereker E, Lynch MA (1999) Neuropeptide Y inhibits glutamate release and long-term potentiation in rat dentate gyrus. Brain Res 827:229–233

    PubMed  CAS  Google Scholar 

  • Widdowson PS, Masten T, Halaris AE (1991) Interactions between neuropeptide Y and alpha 2-adrenoceptors in selected brain regions. Peptides 12:71–75

    PubMed  CAS  Google Scholar 

  • Wiley JW, Gross RA, MacDonald RL (1993) Agonists for neuropeptide Y receptor subtypes NPY-1 and NPY-2 have opposite effects on rat no dose neuron calcium currents. J Neurophysiol 70:324–330

    PubMed  CAS  Google Scholar 

  • Wong-Dusting HK, Rand MJ (1988) Pre and postjunctional effects of neuropeptide Y in the rabbit isolated ear artery. Clin Exp Pharm Physiol 15:411–418

    CAS  Google Scholar 

  • Yang Y-P, Chiba S (2002) Antagonistic interaction between BIIE 0246, a neuropeptide Y Y2-receptor antagonist and ω-conotoxin GVIA, a Ca2+ channel antagonist in presynaptic transmitter release in dog splenic arteries. Jap J Pharmacol 89:108–191

    Google Scholar 

  • Yang T, Levy MN (1993) Effects of intense antecedent sympathetic stimulation on sympathetic neurotransmission in the heart. Circ Res 72:137–144

    PubMed  CAS  Google Scholar 

  • Yokoo H, Schlesinger DH, Goldstein M (1987) The effect of neuropeptide Y on stimulation-evoked release of 3H-norepinephrine from rat hypothalamic and cerebral cortical slices. Eur J Pharmacol 143:283–286

    PubMed  CAS  Google Scholar 

  • Zidichouski JA, Chen H, Smith PA (1990) Neuropeptide Y activates inwardly-rectifying K+ channels in C-cells of amphibian sympathetic ganglia. Neurosci Lett 117:123–128

    PubMed  CAS  Google Scholar 

  • Zukowska-Grojec Z, Vaz CA (1988) Role of neuropeptide Y in the cardiovascular response to stress. Synapse 2:293–298

    PubMed  CAS  Google Scholar 

  • Zukowska-Grojec Z, Konarska M, McCarty R (1988) Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. Life Sci 42:1615–1624

    PubMed  CAS  Google Scholar 

  • Zukowska-Grozecz, Shen GH, Deka-Starosta A, Myers KA, Kvetnansky R, McCarty R (1992) Neuronal, adrenomodullary and platelet derived neuropeptide Y response to stress in rats. In: Kvetnasky R, McCarty R, Axelrod J (eds). Stress: neuroendocrine and molecular approches. Gordon and Breach Science Publishers, New York, pp 197–209

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, 1402 S. Grand Blvd., St. Louis, MO, 63104-1083, USA

    T. C. Westfall

Authors
  1. T. C. Westfall
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Afd. Farmacologie & Farmacotherapie, Academisch Medisch Centrum, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands

    Martin C. Michel

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Westfall, T.C. (2004). Prejunctional Effects of Neuropeptide Y and Its Role as a Cotransmitter. In: Michel, M.C. (eds) Neuropeptide Y and Related Peptides. Handbook of Experimental Pharmacology, vol 162. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18764-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18764-3_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62282-3

  • Online ISBN: 978-3-642-18764-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation